Furthermore, survival and correlation analysis revealed that SHMT2 expression was an independent prognostic factor for recurrence-free survival and disease-specific survival in gastric cancer, oesophageal cancer and CRC 25. Here, SHMT2 is linked to carcinoma of esophagus.